MetaCap

Zai Lab Earnings

NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD

24.99+0.18 (+0.73%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

Zai Lab earnings summary

Zai Lab is scheduled to report Sep/2026 earnings on Nov 5, 2026. In its most recent report on Aug 6, 2026 (Q2 2026), ZLAB posted EPS of $-0.05. Revenue for the quarter was $106.3 million.

Across the last 16 reports, ZLAB shares moved an average of 6.6% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

ZLAB earnings history

Zai Lab reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 6, 2026—$-0.05—+11.1%
May 7, 2026—$-0.05—+10.7%
Feb 26, 2026—$-0.05—+1.7%
Nov 6, 2025—$-0.03—-0.7%
Aug 7, 2025—$-0.04—+2.2%
May 8, 2025—$-0.04—+5.8%
Feb 27, 2025—$-0.09—+5.1%
Nov 12, 2024—$-0.04—-2.3%
Aug 6, 2024—$-0.08—+5.0%
May 8, 2024—$-0.05—-3.4%
Feb 27, 2024—$-0.10—-10.4%
Nov 7, 2023—$-0.07—-2.1%
Aug 7, 2023—$-0.13—-11.9%
May 9, 2023—$-0.05—-6.2%
Mar 1, 2023—$-0.06—-20.1%
Nov 9, 2022—$-0.17—-7.4%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related